Nuveen Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-213,362
Closed -$17.7M 3242
2022
Q3
$17.7M Sell
213,362
-7,333
-3% -$610K 0.01% 1100
2022
Q2
$18.3M Buy
220,695
+24,177
+12% +$2.01M 0.01% 1096
2022
Q1
$23M Sell
196,518
-2,941
-1% -$344K 0.01% 1105
2021
Q4
$21M Sell
199,459
-21,597
-10% -$2.27M 0.01% 1206
2021
Q3
$29.8M Sell
221,056
-8,460
-4% -$1.14M 0.01% 997
2021
Q2
$22.3M Buy
229,516
+5,407
+2% +$525K 0.01% 1277
2021
Q1
$15.3M Sell
224,109
-147,324
-40% -$10.1M ﹤0.01% 1517
2020
Q4
$31.8M Buy
371,433
+95,799
+35% +$8.21M 0.01% 948
2020
Q3
$17.9M Sell
275,634
-25,496
-8% -$1.66M 0.01% 1121
2020
Q2
$22M Buy
301,130
+116,876
+63% +$8.54M 0.01% 983
2020
Q1
$6.27M Sell
184,254
-280,553
-60% -$9.55M ﹤0.01% 1578
2019
Q4
$25.3M Sell
464,807
-402,265
-46% -$21.9M 0.01% 1038
2019
Q3
$36.2M Sell
867,072
-18,953
-2% -$791K 0.01% 824
2019
Q2
$38.8M Buy
+886,025
New +$38.8M 0.02% 814